.svg)
Dr. Emerson Perin Leads DREAM-HF Trial – Demonstrating the Life-Saving Potential of Cell Therapy
Dr. Emerson C. Perin, Medical Director at The Texas Heart Institute, has been highlighted as the lead investigator in the...
Research & Innovations
ReVolutionary Heart Pump Offers New Hope for Infants with Congenital Heart Disease
A dedicated team of researchers and physicians are closer to realizing their hopes of a new device that will change...
7 Hills Pharma Announces First Patient in Phase 1b/2a Clinical Trial Testing Alintegimod Against aPD-1-resistant Solid Tumors
The Texas Heart Institute is excited to share the groundbreaking progress of 7 Hills Pharma Inc. (“7 Hills”), a clinical-stage...
Exploring the Future of Stem Cell Therapy in Cardiac Care: A Collaboration Between The Texas Heart Institute and Rice University
On Friday, September 13, 2024, the Rice University Baker Institute Center for Health and Biosciences and The Texas Heart Institute...
Dr. Jennifer Cozart Pioneers First Use of AtriClip FLEX-Mini in Texas, Advancing Heart Surgery Innovation
Another groundbreaking moment in cardiovascular surgery has again unfolded at The Texas Heart Institute. Dr. Jennifer Cozart, a leading cardiovascular...
Dr. Emerson Perin Participates in UofL Clinical Trial for New Investigational Therapy for Heart Failure
The Texas Heart Institute’s Emerson Perin, MD is collaborating with University of Louisville (UofL) on a new investigational stem cell...
News Around the World: BiVACOR Total Artificial Heart Makes History
The Texas Heart Institute, located in the heart of the Texas Medical Center, broadcasted a live press conference from The...
The Texas Heart Institute Provides BiVACOR® Total Artificial Heart Patient Update
Successful first-in-human bridge to heart transplant with revolutionary valveless artificial heart Houston, Texas, July 26, 2024 – The Texas Heart...
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
First-in-human novel valveless artificial heart implanted in a patient with end-stage heart failure as a bridge to heart transplant ...
A Discovery by The Texas Heart Institute & 7 Hills Pharma Continues Development under a $4.7 Million CPRIT Grant to Address Cancer Treatment Disparities
Peter Vanderslice, PhD, Senior Investigator and Director, MCRL, Molecular Cardiology Research, was highlighted in a recent announcement from 7 Hills Pharma,...
Dr. Matthew Segar Recognized With DEI Abstract Award From Heart Rhythm Society
Novel Machine Learning Model Improves Prediction of Atrial Fibrillation Risk The Heart Rhythm Society recently recognized Matthew Segar, MD,...
Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia
Dr. Christie Mitchell Ballantyne, editorial board member for The Texas Heart Institute Journal, and professor of medicine and chief of...
